United Biomedical-Asia (UBI-Asia) Announces Phase 1/2 and Phase 1 Extension Trial Results of Multitope SARS-CoV-2 Vaccine Published in the Journal of Clinical Investigation
/PRNewswire/ -- United Biomedical, Inc.-Asia (UBI-Asia), a Taiwan-based biologics company innovating antibody and long-acting protein biopharmaceutical...
Source: prnewswire.com